000 00572nam a2200193Ia 4500
008 220913s9999 xx 000 0 und d
041 _aeng
082 _a615. 5 JEE
100 _aJeesa George
245 _aPharmacovigilance during the pre-approval phases-comparison of ICH E2E, CIOMS VI, FDA, EMEA/CHMP & CDSCO risk mangement guidelines
250 _a1
260 _aMysore
_bJSSCP
_c2014
300 _a83p.
502 _aSavitha R S
502 _bJSS University
502 _cClinical Practice and Research
650 _aClinical Pharmacy
906 _a2015-16
999 _c183680
_d183680